Home Page
Sunlight Medical Announces the U.S. Launch of Sunlight OmnisenseTM 7000S Bone Sonometer Offering High-Precision Bone Strength Assessment at the Point of Care
Somerset, NJ, USA (March 9, 2001) Sunlight Medical, Inc. announced the U.S. launch of the Sunlight OmnisenseTM 7000S bone sonometer, a bone strength assessment device equipped with patented OmnipathTM axial transmission technology. The device is an office-based solution to aid physicians in the diagnosis of osteoporosis and to easily monitor bone changes over time at the point of care. Clinical studies around the world confirm its accuracy and high precision level. The Sunlight OmnisenseTM 7000S is the first non-X-ray based device with a Food and Drug Administration (FDA)-approved claim for monitoring bone changes between the ages 50-65.

"Osteoporosis is a major threat to the world's aging population, and with more than 28 million Americans at risk, physicians and their patients want more than occasional testing," says Markus Maritz, president of Sunlight Medical, Inc. "Omnisense 7000S offers a total solution for osteoporosis management and follow-up that the physician can easily offer and rely on right in the office."

Maritz states that the Omnisense 7000S has other features that will be useful to the physician, such as a built-in record management database and patient scheduling. He also notes that the test procedure is fast and comfortable for the patient, and operation of the device is easy to learn and simple for the operator.

The Omnisense 7000Sís patented technology, OmnipathTM, is a new concept in bone strength assessment. OmnipathTM technology non-invasively measures the speed of ultrasonic waves (SOS) propagating axially along the distal 1/3 radius. According to Irit Yaniv, MD, medical director at Sunlight Medical, "By measuring along the bone, OmnipathTM technology eliminates inaccuracies caused by soft tissue factors and provides a comprehensive picture of bone strength taking into account such properties as bone mineral density, elasticity, cortical thickness, and micro-architecture, ultimately delivering a more accurate assessment of fracture risk."

A substantial body of clinical evidence supports Sunlight claims for the Sunlight OmnisenseTM 7000S and its OmnipathTM technology. Various studies, including studies detailed in Clinical Densitometry (Vol. 3, no.1, 1-7, spring 2000) and Osteoporosis International (2000 11:411-416) substantiate Sunlightís claims of high accuracy and precision, qualities that enable it to monitor bone changes over time.